Spironolactone
SIGMA/S3378 - 97.0-103.0%
Synonym: 4-Pregnen-21-oic acid-17α-ol-3-one-7α-thiol γ-lactone 7-acetate; 7α-(Acetylthio)-17α-hydroxy-3-oxopregn-4-ene-21-carboxylic acid γ-lactone
CAS Number: 52-01-7
Empirical Formula (Hill Notation): C24H32O4S
Molecular Weight: 416.57
EC Number: 200-133-6
MDL Number: MFCD00082250
Linear Formula: C24H32O4S
Product Type: Chemical
| assay | 97.0-103.0% |
| InChI | 1S/C24H32O4S/c1-14(25)29- |
| InChI key | LXMSZDCAJNLERA-ZHYRCANASA |
| mp | 207-208 °C (lit.) |
| Quality Level | 200 ![]() |
| SMILES string | CC(=O)S[C@@H]1CC2=CC(=O)C |
| solubility | chloroform: complete 50 mg/ml, clear, faintly yellow |
| Application: | Spironolactone was added to rat diet to study the effect of long-term spironolactone use on renal function. |
| Biochem/physiol Actions: | Spironolactone is a competitive aldosterone receptor antagonist. Used as potassium sparing diuretic. |
| Biochem/physiol Actions: | Spironolactone reduces aldosterone-induced potassium/magnesium loss and myocardial fibrosis. It reduces hypertension, improves the endothelial function and reduces the overall morbidity and mortality in patients with chronic heart failure. Spironolactone improves nitric oxide bioactivity and vascular endothelial vasodilator dysfunction. |
| Features and Benefits: | This compound is featured on the Nuclear Receptors (Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 1, 5 g in glass bottle |
| Preparation Note: | Spironolactone yields clear, faint yellow solution in chloroform at 50 mg/ml. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360FD |
| Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| Hazard Codes | T |
| Risk Statements | 60 |
| Safety Statements | 53-22-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | 97.0-103.0% |
| mp | 207-208 °C (lit.) |
| UNSPSC | 51111800 |


